Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $367 Billion
  • Q3 2024

Artia Global Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $367 Billion distributed in 45 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $88.3B, Eli Lilly & CO with a value of $82B, Viking Therapeutics, Inc. with a value of $33.7B, Intra Cellular Therapies, Inc. with a value of $15.8B, and Astrazeneca PLC with a value of $14.9B.

Examining the 13F form we can see an decrease of $150B in the current position value, from $517B to 367B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $367 Billion
Healthcare: $350 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$744B
$82 Billion 22.36% of portfolio
92,593
Q4 2023 Added 253.5%
$205B
$14.9 Billion 4.05% of portfolio
190,752
Q2 2023 Added 86.45%

Summary

  • Portfolio
  • No. of Stocks 45
  • Current Value $367 Billion
  • Prior Value $517 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 7 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email